Award
National Institute of Allergy and Infectious Diseases 7R01AI184880-02
Determining role of 14-3-3zeta in IL-17A signaling
Recipient
University of Kentucky
Award Amount
$795,696.00
Ceiling
$795,696.00
Awarded
June 12, 2025
Identifier
7R01AI184880-02
NIH-funded research project awarded to University of Kentucky to investigate the role of 14-3-3zeta in IL-17A signaling related to autoimmune diseases, focusing on molecular mechanisms and disease models.
Description
Research project to study the molecular mechanisms, consequences, and physiological relevance of 14-3-3z-TRAF interactions in IL-17A signaling and rheumatoid arthritis, aiming to elucidate fundamental knowledge of IL-17A signaling and autoimmune diseases.